Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 21, 2014; 20(35): 12574-12580
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12574
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12574
Table 1 Patient characteristics
| Patient characteristics | n (%) |
| Age at diagnosis (yr) | 262 (34) |
| Gender | |
| Male | 127 (48.5) |
| Female | 135 (51.5) |
| Extent of the disease | |
| Proctitis | 43 (16.4) |
| Proctosigmoiditis | 47 (17.9) |
| Left-sided colitis | 50 (19.1) |
| Pancolitis | 114 (43.5) |
| Unknown | 8 (3.0) |
| Extraintestinal manifestations | |
| Eyes | 2 (0.8) |
| Skin | 6 (2.3) |
| Joints | 50 (19.1) |
| Immunosuppressive therapy | |
| Azathioprine | 98 (94.2) |
| 6-Mercaptopurine | 23 (22.1) |
| Infliximab | 36 (34.6) |
| Adalimumab | 3 (2.9) |
| Golimumab | 1 (1.0) |
| Methotrexate | 3 (2.9) |
| Miscellaneous | 12 (11.5) |
| Reason for IT | |
| Steroid-refractory disease course | 40 (38.4) |
| Chronic-active disease course | 31 (29.8) |
| Steroid-dependent disease course | 27 (26.0) |
| Miscellaneous | 6 (5.8) |
- Citation: Stallmach A, Nickel L, Lehmann T, Bokemeyer B, Bürger M, Hüppe D, Kruis W, Nikolaus S, Preiss JC, Sturm A, Teich N, Schmidt C. Parameters of a severe disease course in ulcerative colitis. World J Gastroenterol 2014; 20(35): 12574-12580
- URL: https://www.wjgnet.com/1007-9327/full/v20/i35/12574.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i35.12574